Korean J Otorhinolaryngol-Head Neck Surg.  2012 Apr;55(4):222-228. 10.3342/kjorl-hns.2012.55.4.222.

Clinical Characteristics and Comorbidities of Hereditary Hemorrhagic Telangiectasia

Affiliations
  • 1Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University College of Medicine, Seoul, Korea. hrjin@paran.com
  • 2Department of Otorhinolaryngology, Boramae Medical Center, Seoul, Korea.

Abstract

BACKGROUND AND OBJECTIVES
Hereditary hemorrhagic telangiectasia (HHT), often manifested as epistaxis, is also manifested in combination with serious comorbid diseases. The authors reviewed 12 cases of HHT and investigated the manifestations and comorbid diseases of HHT in the Korean population.
SUBJECTS AND METHOD
Medical records of the HHT patients in our department from July 2004 to December 2011 were reviewed retrospectively. Twelve patients who had been classified as definite or possible HHT according to the Curacao criteria were enrolled in this study. Clinical manifestations, treatment methods, results, and comorbid diseases were investigated.
RESULTS
Recurrent epistaxis occurred in 100% of the patients. Epistaxis was managed by bipolar or laser cauterization (n=9), embolization of the feeding vessel (n=1), intranasal application of bevacizumab (Avastin(R))(n=2) or septodermoplasty (n=1). The symptoms of seven patients showed much improvement while the other two did not. Comorbid diseases included pulmonary arteriovenous malformation (AVM) in 5 patients (41.7%) and cerebral AVM in 2 patients (16.7%). Three patients with pulmonary AVM received embolization and one patient with cerebral AVM received gamma knife surgery with good prognosis.
CONCLUSION
Epistaxis by HHT can be improved by active treatment using various methods. Pulmonary and cerebral AVMs are common comorbid diseases and should be considered in the management of HHT.

Keyword

Hereditary hemorrhagic telangiectasia; Epistaxis; Vascular malformations

MeSH Terms

Antibodies, Monoclonal, Humanized
Arteriovenous Malformations
Comorbidity
Epistaxis
Glycosaminoglycans
Humans
Medical Records
Retrospective Studies
Telangiectasia, Hereditary Hemorrhagic
Vascular Malformations
Bevacizumab
Antibodies, Monoclonal, Humanized
Glycosaminoglycans
Full Text Links
  • KJORL-HN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr